Skip to main content
UniHealth

Doctor search

Jui-Li Chang, FNP

Family · Saratoga

NPI 1821038068

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Jui-Li Chang’s office at (408) 379-1626 to ask if they take your plan before you enroll.

California Medical Board record

Licence C11837 · Cancelled

Licence status: Cancelled · since 1949 · University of Texas Medical Branch at Galveston.

License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.

Matched on the licence number without its letter prefix; check the name before relying on it.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Drugs they prescribed that Part D paid

$32,086

Pharmacies billed $32,086 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 9% of their Part D prescriptions (86 of 988) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.

919 generic and 69 brand-name prescriptions · $32,086 in drug cost · 15 antibiotic prescriptions · 17 antipsychotic prescriptions to people over 65.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Pregabalin30$6,029$201
Eliquis16$4,752$297
Megestrol Acetate15$1,957$130
Donepezil Hcl Odt12$1,424$119
Glimepiride102$1,242$12
See all 25 drugs
Every Part D drug this clinician prescribed
Pregabalin30$6,029$201
Eliquis16$4,752$297
Megestrol Acetate15$1,957$130
Donepezil Hcl Odt12$1,424$119
Glimepiride102$1,242$12
Gabapentin122$789$6
Hydrocodone-Acetaminophen37$635$17
Memantine11$542$49
Divalproex52$530$10
Clonazepam29$385$13
Pioglitazone46$379$8
Zolpidem37$344$9
Tramadol24$294$12
Quetiapine17$281$17
Amlodipine Besylate50$255$5
Levothyroxine25$213$9
Losartan15$191$13
Pantoprazole24$187$8
Lisinopril36$144$4
Furosemide31$141$5
Atorvastatin25$131$5
Mirtazapine15$123$8
Metoprolol16$107$7
Escitalopram16$77$5
Metformin11$43$4

Year by year

Part D prescribing by year
20249881059% (86)7%$32,086
2023699916% (43)7%$26,143
20223545811% (38)8%$23,617
20215046511% (53)10%$29,819
20201945113% (25)32%$28,451
20191644820% (32)None$23,243
20182355516% (38)53%$25,127
20172586129% (75)35%$24,075
20163355638% (127)24%$25,302
20152614644% (114)None$14,137
2014942823% (22)13%$2,786
2013839852% (20)None$29,035

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 19 drugs

Part D drugs prescribed in 2023
Pregabalin28$4,444$159
Megestrol Acetate13$2,359$181
Glimepiride97$956$10
Amantadine25$823$33
Carbidopa-Levodopa Er16$677$42
Hydralazine33$474$14
Donepezil Hcl Odt11$328$30
Levothyroxine29$315$11
Gabapentin44$276$6
Hydrocodone-Acetaminophen14$245$17
Donepezil26$234$9
Metformin37$219$6
Amlodipine Besylate28$206$7
Tramadol22$197$9
Zolpidem19$147$8
Furosemide22$118$5
Metoprolol24$117$5
Lisinopril17$80$5
Mirtazapine11$69$6

2022: 9 drugs

Part D drugs prescribed in 2022
Pregabalin30$4,792$160
Eliquis14$3,690$264
Glimepiride59$498$8
Gabapentin45$442$10
Metformin53$265$5
Atorvastatin21$230$11
Hydrocodone-Acetaminophen13$165$13
Tramadol14$92$7
Amlodipine Besylate13$73$6

2021: 12 drugs

Part D drugs prescribed in 2021
Eliquis25$6,229$249
Xarelto12$6,202$517
Pregabalin34$5,226$154
Carbidopa-Levodopa47$531$11
Gabapentin47$503$11
Atorvastatin57$407$7
Glimepiride38$288$8
Metformin46$206$4
Tramadol26$198$8
Hydrocodone-Acetaminophen16$194$12
Amlodipine Besylate37$145$4
Hydrochlorothiazide35$122$3

2020: 6 drugs

Part D drugs prescribed in 2020
Eliquis25$5,903$236
Pregabalin14$1,229$88
Potassium Chloride21$161$8
Tramadol19$142$7
Hydrochlorothiazide12$88$7
Furosemide13$54$4

2019: 6 drugs

Part D drugs prescribed in 2019
Lyrica30$5,715$190
Renvela11$2,733$248
Gabapentin18$361$20
Hydrocodone-Acetaminophen16$276$17
Tramadol16$113$7
Furosemide15$93$6

2018: 4 drugs

Part D drugs prescribed in 2018
Lyrica100$19,227$192
Hydrocodone-Acetaminophen13$182$14
Tramadol24$168$7
Metformin11$81$7

2017: 4 drugs

Part D drugs prescribed in 2017
Lyrica78$17,225$221
Hydrocodone-Acetaminophen45$913$20
Gabapentin21$322$15
Tramadol29$282$10

2016: 9 drugs

Part D drugs prescribed in 2016
Lyrica61$17,436$286
Hydrocodone-Acetaminophen70$1,652$24
Oxycodone-Acetaminophen14$1,065$76
Duloxetine13$427$33
Gabapentin25$273$11
Tramadol35$187$5
Clonazepam12$74$6
Fluoxetine11$49$4
Cyclobenzaprine11$44$4

2015: 7 drugs

Part D drugs prescribed in 2015
Lyrica33$9,941$301
Hydrocodone-Acetaminophen67$1,584$24
Gabapentin25$248$10
Tramadol32$176$6
Fluoxetine15$57$4
Clonazepam12$39$3
Cyclobenzaprine11$38$3

2013: 19 drugs

Part D drugs prescribed in 2013
Januvia14$5,134$367
Diovan16$2,949$184
Amlodipine Besylate81$606$7
Losartan40$537$13
Simvastatin67$502$7
Lisinopril55$353$6
Levothyroxine47$308$7
Atenolol43$294$7
Alendronate30$267$9
Omeprazole11$244$22
Hydrocodone-Acetaminophen14$220$16
Gemfibrozil13$198$15
Topiramate21$195$9
Metformin26$176$7
Glimepiride20$157$8
Pravastatin11$148$13
Hydrochlorothiazide33$146$4
Sertraline14$122$9
Fluoxetine13$78$6

Money from drug and device companies

$19 in 2023

Industry payments by year
202311None$19
202211None$32
202111None$13

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
GlaxoSmithKlineTrelegy Ellipta$19
1 payment
  • Meals for Trelegy Ellipta · 2023-03-03 · $19
See the published payment
Every published payment
GlaxoSmithKlineMeals · 2023-03-03Trelegy Ellipta$19
See earlier years (2022, 2021)

2022: $32

Payments by company in 2022
GlaxoSmithKlineTrelegy Ellipta$32
1 payment
  • Meals for Trelegy Ellipta · 2022-03-10 · $32

2021: $13

Payments by company in 2021
GlaxoSmithKlineTrelegy Ellipta$13
1 payment
  • Meals for Trelegy Ellipta · 2021-11-04 · $13

Professional record

NPI
1821038068
Licence
CA 11837California C11837: Cancelled
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 363LF0000X (363LF0000X)
Mailing address
13164 Kevin St, Saratoga, CA, 95070
NPI first listed
2006-06-07
NPI last updated
2018-03-17

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 734 Mowry Ave, Fremont, CA, 94536